Cargando…
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
While many studies have evaluated the relationship between BMI and breast cancer outcomes, it is unclear whether this relationship is consistent between early breast cancer (BC) and advanced BC. The study included 5099 patients with HER2 positive early BC (EBC) and 3496 with HER2 positive advanced B...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985140/ https://www.ncbi.nlm.nih.gov/pubmed/33753745 http://dx.doi.org/10.1038/s41523-021-00241-9 |
_version_ | 1783668179680100352 |
---|---|
author | Modi, Natansh D. Tan, Jin Quan Eugene Rowland, Andrew Koczwara, Bogda Abuhelwa, Ahmad Y. Kichenadasse, Ganessan McKinnon, Ross A. Wiese, Michael D. Sorich, Michael J. Hopkins, Ashley M. |
author_facet | Modi, Natansh D. Tan, Jin Quan Eugene Rowland, Andrew Koczwara, Bogda Abuhelwa, Ahmad Y. Kichenadasse, Ganessan McKinnon, Ross A. Wiese, Michael D. Sorich, Michael J. Hopkins, Ashley M. |
author_sort | Modi, Natansh D. |
collection | PubMed |
description | While many studies have evaluated the relationship between BMI and breast cancer outcomes, it is unclear whether this relationship is consistent between early breast cancer (BC) and advanced BC. The study included 5099 patients with HER2 positive early BC (EBC) and 3496 with HER2 positive advanced BC (ABC). In the EBC cohort, higher BMI was associated with worse overall survival (OS) (HR [95% CI]: overweight = 1.30 [1.13–1.51]; obese = 1.37 [1.14–1.64], P = < 0.001), and worse disease-free survival (overweight = 1.10 [0.98–1.24]; obese = 1.20 [1.04–1.39], P = 0.061). In contrast, for the ABC cohort, higher BMI was significantly associated with improved OS (overweight = 0.85 [0.76–0.96]; obese = 0.82 [0.72–0.95], P = 0.014), and progression-free survival (overweight = 0.91 [0.83–1.01]; obese = 0.87 [0.77–0.98], P = 0.034). In this large high-quality dataset, higher BMI was independently associated with worse survival in EBC, paradoxically in ABC higher BMI was independently associated with improved survival. |
format | Online Article Text |
id | pubmed-7985140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79851402021-04-12 The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data Modi, Natansh D. Tan, Jin Quan Eugene Rowland, Andrew Koczwara, Bogda Abuhelwa, Ahmad Y. Kichenadasse, Ganessan McKinnon, Ross A. Wiese, Michael D. Sorich, Michael J. Hopkins, Ashley M. NPJ Breast Cancer Article While many studies have evaluated the relationship between BMI and breast cancer outcomes, it is unclear whether this relationship is consistent between early breast cancer (BC) and advanced BC. The study included 5099 patients with HER2 positive early BC (EBC) and 3496 with HER2 positive advanced BC (ABC). In the EBC cohort, higher BMI was associated with worse overall survival (OS) (HR [95% CI]: overweight = 1.30 [1.13–1.51]; obese = 1.37 [1.14–1.64], P = < 0.001), and worse disease-free survival (overweight = 1.10 [0.98–1.24]; obese = 1.20 [1.04–1.39], P = 0.061). In contrast, for the ABC cohort, higher BMI was significantly associated with improved OS (overweight = 0.85 [0.76–0.96]; obese = 0.82 [0.72–0.95], P = 0.014), and progression-free survival (overweight = 0.91 [0.83–1.01]; obese = 0.87 [0.77–0.98], P = 0.034). In this large high-quality dataset, higher BMI was independently associated with worse survival in EBC, paradoxically in ABC higher BMI was independently associated with improved survival. Nature Publishing Group UK 2021-03-22 /pmc/articles/PMC7985140/ /pubmed/33753745 http://dx.doi.org/10.1038/s41523-021-00241-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Modi, Natansh D. Tan, Jin Quan Eugene Rowland, Andrew Koczwara, Bogda Abuhelwa, Ahmad Y. Kichenadasse, Ganessan McKinnon, Ross A. Wiese, Michael D. Sorich, Michael J. Hopkins, Ashley M. The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title | The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title_full | The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title_fullStr | The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title_full_unstemmed | The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title_short | The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data |
title_sort | obesity paradox in early and advanced her2 positive breast cancer: pooled analysis of clinical trial data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985140/ https://www.ncbi.nlm.nih.gov/pubmed/33753745 http://dx.doi.org/10.1038/s41523-021-00241-9 |
work_keys_str_mv | AT modinatanshd theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT tanjinquaneugene theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT rowlandandrew theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT koczwarabogda theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT abuhelwaahmady theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT kichenadasseganessan theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT mckinnonrossa theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT wiesemichaeld theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT sorichmichaelj theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT hopkinsashleym theobesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT modinatanshd obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT tanjinquaneugene obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT rowlandandrew obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT koczwarabogda obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT abuhelwaahmady obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT kichenadasseganessan obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT mckinnonrossa obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT wiesemichaeld obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT sorichmichaelj obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata AT hopkinsashleym obesityparadoxinearlyandadvancedher2positivebreastcancerpooledanalysisofclinicaltrialdata |